David A. Siegel Dr Reddys Laboratories LTD Transaction History

Two Sigma Advisers, LP

$43.8 Billion
Q2 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 14,300 shares of RDY stock, worth $208,208. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,300

Previous 13,800 3.62%

Holding current value

$208,208

Previous $1.01 Million 7.61%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$68.26 - $76.19 $34,130 - $38,095	500 Added 3.62%	14,300 $1.09 Million
Q1 2024 May 15, 2024	SELL	$67.36 - $77.59 $2.88 Million - $3.31 Million	-42,700 Reduced 75.58%	13,800 $1.01 Million
Q4 2023 Feb 14, 2024	SELL	$64.27 - $69.9 $4.32 Million - $4.7 Million	-67,200 Reduced 54.32%	56,500 $3.93 Million
Q3 2023 Nov 14, 2023	SELL	$61.9 - $72.77 $2.25 Million - $2.64 Million	-36,300 Reduced 22.69%	123,700 $8.27 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $4.07 Million - $4.82 Million	76,300 Added 91.16%	160,000 $10.1 Million
Q1 2023 May 15, 2023	BUY	$51.63 - $56.93 $4.32 Million - $4.77 Million	83,700 New	83,700 $4.77 Million
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $314,370 - $361,116	-6,300 Reduced 54.31%	5,300 $277,000
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $69,468 - $81,382	-1,400 Reduced 10.77%	11,600 $643,000
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $627,510 - $848,250	13,000 New	13,000 $724,000
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $327,250 - $369,875	-5,500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$60.19 - $75.29 $331,045 - $414,095	5,500 New	5,500 $358,000
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $275,484 - $313,676	-4,400 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$51.39 - $72.41 $2.22 Million - $3.13 Million	-43,200 Reduced 90.76%	4,400 $306,000
Q2 2020 Aug 14, 2020	BUY	$39.55 - $54.65 $1.28 Million - $1.77 Million	32,300 Added 211.11%	47,600 $2.52 Million
Q1 2020 May 15, 2020	SELL	$34.75 - $45.85 $128,575 - $169,645	-3,700 Reduced 19.47%	15,300 $617,000
Q4 2019 Feb 14, 2020	BUY	$36.66 - $41.78 $21,995 - $25,068	600 Added 3.26%	19,000 $771,000
Q3 2019 Nov 14, 2019	SELL	$34.82 - $39.26 $17,410 - $19,630	-500 Reduced 2.65%	18,400 $697,000
Q2 2019 Aug 14, 2019	BUY	$36.05 - $42.76 $681,345 - $808,164	18,900 New	18,900 $708,000
Q4 2018 Feb 14, 2019	SELL	$31.89 - $38.44 $1.92 Million - $2.31 Million	-60,100 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$29.25 - $36.73 $5.74 Million - $7.21 Million	-196,300 Reduced 76.56%	60,100 $2.08 Million
Q2 2018 Aug 14, 2018	BUY	$28.49 - $35.06 $7.1 Million - $8.73 Million	249,100 Added 3412.33%	256,400 $8.26 Million
Q1 2018 May 15, 2018	BUY	$31.93 - $39.54 $233,089 - $288,642	7,300 New	7,300 $239,000

Others Institutions Holding RDY

# of Institutions

238

Shares Held

24.2M

Call Options Held

14.6K

Put Options Held

2.8K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.42B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account